Erythritol, Erythronate, and Cardiovascular Outcomes in Older Adults in the ARIC Study
Circulating erythritol and erythronate levels are markers of cardiometabolic health and cardiovascular outcomes in an older adult population. In particular, erythronate is associated with all cardiovascular outcomes assessed. Future studies should assess the role of erythronate and its related pathways in cardiovascular disease.
Authors
- Chiadi E. Ndumele (ORCID: https://orcid.org/0000-0002-1603-282X)
- Ashok Balasubramanyam (ORCID: https://orcid.org/0000-0003-2093-5201)
- Jane E.B. Reusch (ORCID: https://orcid.org/0000-0001-8620-1003)
- Caroline Sun (ORCID: https://orcid.org/0000-0002-3192-0067)
- Ron Cornelis Hoogeveen (ORCID: https://orcid.org/0000-0003-2399-4653)
- Mark A. Herman (ORCID: https://orcid.org/0000-0001-6979-103X)
- Christie Mitchell Ballantyne (ORCID: https://orcid.org/0000-0002-6432-1730)
- Layla A. Abushamat (ORCID: https://orcid.org/0000-0002-4074-881X)
- Sean M. Hartig (ORCID: https://orcid.org/0000-0002-2695-2072)
- Bing Yu (ORCID: https://orcid.org/0000-0003-4818-1077)
- Chao Cheng (ORCID: https://orcid.org/0000-0002-5002-3417)
- Vijay Nambi (ORCID: https://orcid.org/0000-0002-4237-0267)
- Elizabeth Selvin (ORCID: https://orcid.org/0000-0002-3539-2070)
Institutions
- Johns Hopkins University (US)
- Baylor College of Medicine (US)
- Rocky Mountain MS Center (US)
- University of Colorado Anschutz Medical Campus (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101605
- Citations
- 4
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- American Diabetes Association
- National Institutes of Health